Related Experiment Video
Updated: Jun 4, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Unlocking the Potential of Senolytic Compounds: Advancements, Opportunities, and Challenges in Ageing-Related
Lilian Sales Gomez1,2, Diana Jurk3,4
1Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
Abstract:
Cellular senescence is recognised as a contributor to the ageing process and the development of multiple age-related conditions. Researchers have launched efforts to identify compounds capable to selectively kill senescent cells, known as senolytics, without affecting non senescent cells. As of now, over 40 compounds have demonstrated senolytic properties, offering promising prospects for reversing or ameliorating age-related conditions in preclinical studies.This chapter presents the most recent developments in senolytic drug research, encompassing investigations spanning basic science, preclinical trials, and clinical studies. While many of these investigations have generated encouraging results in the realm of age-related interventions, this chapter also addresses potential challenges and pitfalls.
Insights
Cellular senescence contributes to aging. Researchers are developing senolytics, drugs that selectively kill senescent cells, to combat age-related diseases with promising preclinical results.
Area of Science:
- Gerontology and Cellular Biology
- Pharmacology and Drug Discovery
Background:
- Cellular senescence is a key factor in aging and age-related diseases.
- Identifying compounds that selectively eliminate senescent cells (senolytics) is a major research focus.
Purpose of the Study:
- To review recent advancements in senolytic drug research.
- To cover basic science, preclinical, and clinical investigations of senolytics.
- To discuss the potential and challenges of senolytic interventions.
Main Methods:
- Literature review of recent senolytic research.
- Analysis of preclinical and clinical study findings.
- Identification of emerging senolytic compounds and strategies.
Main Results:
- Over 40 compounds show senolytic activity in preclinical studies.
- Senolytics demonstrate potential for reversing or improving age-related conditions.
- Encouraging results have been observed in various age-related intervention studies.
Conclusions:
- Senolytic drug development is a rapidly advancing field with significant therapeutic potential.
- Further research is needed to address challenges and optimize senolytic therapies for clinical use.
- Senolytics offer a promising avenue for combating age-related diseases and promoting healthy aging.
More Related Videos
Related Concept Videos
Mitochondria
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

